DNA repair: A potential marker for cancer susceptibility

Q. Wei, Genevieve Matanoski, E. R. Farmer, M. A. Hedayati, L. Grossman

Research output: Contribution to journalArticle

Abstract

DNA REPAIR in the etiology of cancer has been implicated in a rare genetic disease, xeroderma pigmentosum. Deficient repair and an extraordinarily high incidence of sunlight-induced skin cancers are coupled in xeroderma pigmentosum patients, which led to the pursuit of DNA repair capacity as a biomarker of cancer susceptibility. Recently a new assay (host cell reactivation [HCR] or chloramphenicol acetyltransferase [CAT] assay) was developed to measure the overall DNA repair capacity in human lymphocytes. Compared to unscheduled DNA synthesis, which has been used in some clinical investigations, the CAT assay is considered more objective, quantitative, and applicable to population studies. Findings suggest that the paradigm of deficient DNA repair vs skin cancer seen in xeroderma pigmentosum is applicable to the general population, suggesting that DNA repair capacity may serve as a useful biomarker for cancer susceptibility.

Original languageEnglish (US)
Pages (from-to)233-237
Number of pages5
JournalCancer Bulletin
Volume46
Issue number3
StatePublished - 1994
Externally publishedYes

Fingerprint

Xeroderma Pigmentosum
DNA Repair
Chloramphenicol O-Acetyltransferase
Skin Neoplasms
Tumor Biomarkers
DNA Repair-Deficiency Disorders
Neoplasms
Inborn Genetic Diseases
Sunlight
DNA
Rare Diseases
Population
Lymphocytes
Incidence

ASJC Scopus subject areas

  • Cancer Research

Cite this

Wei, Q., Matanoski, G., Farmer, E. R., Hedayati, M. A., & Grossman, L. (1994). DNA repair: A potential marker for cancer susceptibility. Cancer Bulletin, 46(3), 233-237.

DNA repair : A potential marker for cancer susceptibility. / Wei, Q.; Matanoski, Genevieve; Farmer, E. R.; Hedayati, M. A.; Grossman, L.

In: Cancer Bulletin, Vol. 46, No. 3, 1994, p. 233-237.

Research output: Contribution to journalArticle

Wei, Q, Matanoski, G, Farmer, ER, Hedayati, MA & Grossman, L 1994, 'DNA repair: A potential marker for cancer susceptibility', Cancer Bulletin, vol. 46, no. 3, pp. 233-237.
Wei Q, Matanoski G, Farmer ER, Hedayati MA, Grossman L. DNA repair: A potential marker for cancer susceptibility. Cancer Bulletin. 1994;46(3):233-237.
Wei, Q. ; Matanoski, Genevieve ; Farmer, E. R. ; Hedayati, M. A. ; Grossman, L. / DNA repair : A potential marker for cancer susceptibility. In: Cancer Bulletin. 1994 ; Vol. 46, No. 3. pp. 233-237.
@article{3a918c4995174ea5ac4c2f562f2d020c,
title = "DNA repair: A potential marker for cancer susceptibility",
abstract = "DNA REPAIR in the etiology of cancer has been implicated in a rare genetic disease, xeroderma pigmentosum. Deficient repair and an extraordinarily high incidence of sunlight-induced skin cancers are coupled in xeroderma pigmentosum patients, which led to the pursuit of DNA repair capacity as a biomarker of cancer susceptibility. Recently a new assay (host cell reactivation [HCR] or chloramphenicol acetyltransferase [CAT] assay) was developed to measure the overall DNA repair capacity in human lymphocytes. Compared to unscheduled DNA synthesis, which has been used in some clinical investigations, the CAT assay is considered more objective, quantitative, and applicable to population studies. Findings suggest that the paradigm of deficient DNA repair vs skin cancer seen in xeroderma pigmentosum is applicable to the general population, suggesting that DNA repair capacity may serve as a useful biomarker for cancer susceptibility.",
author = "Q. Wei and Genevieve Matanoski and Farmer, {E. R.} and Hedayati, {M. A.} and L. Grossman",
year = "1994",
language = "English (US)",
volume = "46",
pages = "233--237",
journal = "Cancer Bulletin",
issn = "0008-5448",
publisher = "Medical Arts Publishing",
number = "3",

}

TY - JOUR

T1 - DNA repair

T2 - A potential marker for cancer susceptibility

AU - Wei, Q.

AU - Matanoski, Genevieve

AU - Farmer, E. R.

AU - Hedayati, M. A.

AU - Grossman, L.

PY - 1994

Y1 - 1994

N2 - DNA REPAIR in the etiology of cancer has been implicated in a rare genetic disease, xeroderma pigmentosum. Deficient repair and an extraordinarily high incidence of sunlight-induced skin cancers are coupled in xeroderma pigmentosum patients, which led to the pursuit of DNA repair capacity as a biomarker of cancer susceptibility. Recently a new assay (host cell reactivation [HCR] or chloramphenicol acetyltransferase [CAT] assay) was developed to measure the overall DNA repair capacity in human lymphocytes. Compared to unscheduled DNA synthesis, which has been used in some clinical investigations, the CAT assay is considered more objective, quantitative, and applicable to population studies. Findings suggest that the paradigm of deficient DNA repair vs skin cancer seen in xeroderma pigmentosum is applicable to the general population, suggesting that DNA repair capacity may serve as a useful biomarker for cancer susceptibility.

AB - DNA REPAIR in the etiology of cancer has been implicated in a rare genetic disease, xeroderma pigmentosum. Deficient repair and an extraordinarily high incidence of sunlight-induced skin cancers are coupled in xeroderma pigmentosum patients, which led to the pursuit of DNA repair capacity as a biomarker of cancer susceptibility. Recently a new assay (host cell reactivation [HCR] or chloramphenicol acetyltransferase [CAT] assay) was developed to measure the overall DNA repair capacity in human lymphocytes. Compared to unscheduled DNA synthesis, which has been used in some clinical investigations, the CAT assay is considered more objective, quantitative, and applicable to population studies. Findings suggest that the paradigm of deficient DNA repair vs skin cancer seen in xeroderma pigmentosum is applicable to the general population, suggesting that DNA repair capacity may serve as a useful biomarker for cancer susceptibility.

UR - http://www.scopus.com/inward/record.url?scp=0028305092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028305092&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0028305092

VL - 46

SP - 233

EP - 237

JO - Cancer Bulletin

JF - Cancer Bulletin

SN - 0008-5448

IS - 3

ER -